In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Can BMS Deliver on Innovation?

Executive Summary

In December of 2007, Bristol-Myers announced its commitment to become a 'next-generation" biopharma company, with a focus on biologics and specialty drugs. That meant it would divest its non-core non-pharma assets, improve productivity, bolster R&D, and make sure its financing was in shape-even as its peers were taking the opposite approach. Two years later, it appears to be successfully executing on its objectives for the first two stages.
Advertisement

Related Content

With The Launch Of Yervoy, Early Signs Of R&D Success For Bristol
Biopharma Trends: Nowhere To Go But Up
Why Doesn't Pharma Get Smaller?
Why Doesn't Pharma Get Smaller?
Bristol-Myers Squibb and Otsuka Stabilize Their Bases
Bristol-Myers Squibb and Otsuka Stabilize Their Bases
ImClone and Bristol: The Acquisition Fight Focuses on the Erbitux Successor
ImClone and Bristol: The Acquisition Fight Focuses on the Erbitux Successor
Bristol Revs Its R&D Engine: An Interview with Elliott Sigal and Francis Cuss
Bristol Revs Its R&D Engine: An Interview with Elliott Sigal and Francis Cuss

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003352

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel